These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6604586)

  • 41. Purification and characterization of a T lymphocyte-derived differentiation-inducing factor for human promyelocytic cell line (HL-60) and its relationship to lymphotoxin.
    Shimizu Y; Nakamura T; Niki T; Hemmi H; Sugamura K
    Microbiol Immunol; 1989; 33(6):489-501. PubMed ID: 2788794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
    Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
    J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice.
    Suzuki S; Huchet R
    Cell Immunol; 1982 Apr; 68(2):349-58. PubMed ID: 6124318
    [No Abstract]   [Full Text] [Related]  

  • 44. Purification of a suppressor lymphokine (SL) from a human T-cell line.
    Abolhassani M; Muraki J; Chiao JW
    Immunol Invest; 1989 Jul; 18(6):741-51. PubMed ID: 2767735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human leukocyte inhibitory factor (LIF): two distinct molecular species.
    Brown AP; Rocklin RE
    J Immunol; 1979 Mar; 122(3):1059-61. PubMed ID: 36430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of hydrogen peroxide-potentiating factor, a lymphokine that increases the capacity of human monocytes and monocyte-like cell lines to produce hydrogen peroxide.
    Gately CL; Wahl SM; Oppenheim JJ
    J Immunol; 1983 Dec; 131(6):2853-8. PubMed ID: 6438232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
    J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages.
    Buchmuller Y; Weiser WY; Remold HG
    Cell Immunol; 1985 Jan; 90(1):242-50. PubMed ID: 3881189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a human monocyte cytotoxicity-inducing factor (MCF).
    Jones CM; Prince CA; Shadduck RK
    Immunobiology; 1988 Dec; 178(3):229-49. PubMed ID: 3068122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-lymphocyte progenitors in man: biochemical characterization of a colony promoting activity (CPA) active on immature precursors.
    Triebel F; Gluckman JC; Debre P; Charron DJ
    Immunology; 1984 Dec; 53(4):651-7. PubMed ID: 6334017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of human macrophage agglutination factor to other fibronectins.
    Godfrey HP; Canfield LS; Haak-Frendscho M; Melancon-Kaplan J; Brown EJ; Kaplan AP
    Immunology; 1989 Jul; 67(3):321-7. PubMed ID: 2788126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF).
    Cruikshank W; Center DM
    J Immunol; 1982 Jun; 128(6):2569-74. PubMed ID: 7042841
    [No Abstract]   [Full Text] [Related]  

  • 55. Purification of murine helper T cell-replacing factors.
    Watson J; Mochizuki D; Gillis S
    Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune modulation of connective tissue functions: studies on the production of collagen synthesis inhibitory factor by populations of human peripheral blood mononuclear cells.
    McArthur W; Derr K; Dixon M; Jimenez SA; Rosenbloom J
    Cell Immunol; 1982 Nov; 74(1):126-39. PubMed ID: 6819090
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of mitogen and lymphokine stimulation on proteoglycan synthesis by lymphocytes.
    Bartold PM; Haynes DR; Vernon-Roberts B
    J Cell Physiol; 1989 Jul; 140(1):82-90. PubMed ID: 2786883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification of human interleukin 2 to apparent homogeneity and partial characterization of its receptor.
    Fagnani R; Cooper HL; Mendelsohn J
    Anal Biochem; 1984 Nov; 142(2):487-96. PubMed ID: 6442106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells.
    Godard A; Gascan H; Naulet J; Peyrat MA; Jacques Y; Soulillou JP; Moreau JF
    Blood; 1988 Jun; 71(6):1618-23. PubMed ID: 3130906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.